L. Sztriha

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M. Bath, Polly Scutt, Jason P. Appleton et al. · The Lancet · 2019 · 194 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study

Richard Perry, Arina Tamborska, Bhagteshwar Singh et al. · The Lancet · 2021 · 190 citations · Full text

Medicine, Immunology, Neurology +12

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton et al. · The Lancet · 2017 · 180 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17